Advancing Precision Medicine in Early Bladder Cancer with Urine Assay Technology
Time: 12:10 pm
day: Day One
Details:
- Urine-based genomic analysis has the potential to become a standard liquid biopsy approach in early bladder cancer
- Urine enables convenient and reliable, non-invasive patient screening, addressing certain challenges of tissue and plasma-based testing
- The highly sensitive method detects a broad spectrum of genomic alterations, enhancing its clinical utility beyond treatment selection
